Prices for brand-name drugs in the U.S. are three times what the same drugs cost in other countries. And in a recent KFF survey, 3 in 10 adults reported not taking their medicine as prescribed at some ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

California Sen. Scott Wiener’s SB 40 & SB 41 aim to reduce prescription costs with insulin affordability & PBM reform ...

Overview: As the Chicago Department of Public Health rolls out an ambitious action plan, Trump’s Project 2025 playbook ...

A bill to stop Pharmacy Benefit Managers or PBMs from giving pharmacies less money than it costs to fill prescriptions advanced through the Iowa House Commerce Committee Tuesday.

Lee also said Trump might well remove the tariffs on Mexico and Canada before May, but he might impose tariffs on the ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

Iowa pharmacists and advocates said Wednesday lawmakers need to pass legislation regulating pharmacy benefit managers (PBMs), the third-party companies that negotiate prescription prices between ...

If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...

In a move that has woken the biomedical research community, the National Institutes of Health (NIH) announced on Friday, ...

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, ...

Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.